Bio Gene Shares Owned By Insiders vs. Revenue
| BGT Stock | 0.04 0 2.33% |
For Bio Gene profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Bio Gene to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Bio Gene Technology utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Bio Gene's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Bio Gene Technology over time as well as its relative position and ranking within its peers.
Bio |
Bio Gene Technology Revenue vs. Shares Owned By Insiders Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Bio Gene's current stock value. Our valuation model uses many indicators to compare Bio Gene value to that of its competitors to determine the firm's financial worth. Bio Gene Technology is number one stock in shares owned by insiders category among its peers. It is rated fifth in revenue category among its peers totaling about 422.80 of Revenue per Shares Owned By Insiders. At this time, Bio Gene's Total Revenue is comparatively stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Bio Gene's earnings, one of the primary drivers of an investment's value.Bio Revenue vs. Shares Owned By Insiders
Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
Bio Gene |
| = | 43.33 % |
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Bio Gene |
| = | 18.32 K |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Bio Revenue vs Competition
Bio Gene Technology is rated fifth in revenue category among its peers. Market size based on revenue of Materials industry is currently estimated at about 41.07 Trillion. Bio Gene adds roughly 18,320 in revenue claiming only tiny portion of all equities under Materials industry.
Bio Gene Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Bio Gene, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Bio Gene will eventually generate negative long term returns. The profitability progress is the general direction of Bio Gene's change in net profit over the period of time. It can combine multiple indicators of Bio Gene, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 907 K | 743.2 K | |
| Operating Income | -3.1 M | -3.2 M | |
| Net Loss | -2.4 M | -2.5 M | |
| Income Before Tax | -3 M | -2.9 M | |
| Total Other Income Expense Net | 49.1 K | 50.9 K | |
| Net Loss | -2.8 M | -2.6 M | |
| Net Loss | -2.4 M | -2.5 M | |
| Income Tax Expense | -604.2 K | -574 K | |
| Net Interest Income | 87 K | 60.4 K | |
| Interest Income | 87 K | 60.7 K | |
| Change To Netincome | 562.1 K | 590.2 K |
Bio Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Bio Gene. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Bio Gene position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Bio Gene's important profitability drivers and their relationship over time.
Use Bio Gene in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bio Gene position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bio Gene will appreciate offsetting losses from the drop in the long position's value.Bio Gene Pair Trading
Bio Gene Technology Pair Trading Analysis
The ability to find closely correlated positions to Bio Gene could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bio Gene when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bio Gene - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bio Gene Technology to buy it.
The correlation of Bio Gene is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bio Gene moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bio Gene Technology moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bio Gene can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Bio Gene position
In addition to having Bio Gene in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Hotels Thematic Idea Now
Hotels
Hotels, inns, motels, and other companies providing lodging and hospitality services. The Hotels theme has 45 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Hotels Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Bio Stock Analysis
When running Bio Gene's price analysis, check to measure Bio Gene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio Gene is operating at the current time. Most of Bio Gene's value examination focuses on studying past and present price action to predict the probability of Bio Gene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bio Gene's price. Additionally, you may evaluate how the addition of Bio Gene to your portfolios can decrease your overall portfolio volatility.